XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech gross margin
Gross margin is gross profit as a percentage of revenue.
XBiotech's gross margin for the twelve months ending Sep 30, 2023 was 94.7%. For fiscal 2022 it was 83.8%, against 68.4% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | 83.8% | +15.4 |
| FY2021 | Dec 31, 2021 | 68.4% | +46.9 |
| FY2020 | Dec 31, 2020 | 21.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | 94.7% | +17.9 |
| Q3 FY2022 | Sep 30, 2022 | 87.2% | +11.8 |
| Q2 FY2022 | Jun 30, 2022 | 86.5% | +16.5 |
| Q1 FY2022 | Mar 31, 2022 | 57.4% | +4.9 |
| Q4 FY2021 | Dec 31, 2021 | 76.8% | +19.4 |
| Q3 FY2021 | Sep 30, 2021 | 75.4% | +64.8 |
| Q2 FY2021 | Jun 30, 2021 | 69.9% | +55.1 |
| Q1 FY2021 | Mar 31, 2021 | 52.5% | +28.8 |
| Q4 FY2020 | Dec 31, 2020 | 57.3% | – |
| Q3 FY2020 | Sep 30, 2020 | 10.6% | – |
| Q2 FY2020 | Jun 30, 2020 | 14.8% | – |
| Q1 FY2020 | Mar 31, 2020 | 23.7% | – |
See a number that looks wrong?